What is Aalto Scientific?
Aalto Scientific operates as a critical infrastructure provider for the diagnostics industry, specializing in the manufacturing of OEM and private label quality controls, calibrators, and purified human proteins. With a legacy spanning over four decades, the company has established a state-of-the-art manufacturing facility that serves as a cornerstone for the IVD manufacturing community. Their core competencies include the production of clinically significant human proteins and bulk human and animal sera, which are essential for maintaining diagnostic accuracy and regulatory compliance. By offering bespoke contract manufacturing services, Aalto Scientific addresses the specific technical requirements of its partners, reinforcing its reputation for precision and reliability in a highly regulated market environment.
How much funding has Aalto Scientific raised?
Aalto Scientific has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Aalto Scientific
PPP
Public-Private Partnership
What's next for Aalto Scientific?
Looking ahead, the infusion of capital is expected to drive operational scaling and technological integration within Aalto Scientific's existing manufacturing framework. As the diagnostics industry faces increasing pressure for higher precision and faster turnaround times, the company is well-positioned to expand its footprint in the global supply chain. Strategic priorities likely include the enhancement of their purified protein portfolio and the optimization of their contract manufacturing workflows to meet the evolving needs of IVD developers. This growth trajectory underscores the company's commitment to maintaining its status as a premier supplier of diagnostic materials, ensuring that their products remain at the forefront of clinical laboratory standards.
See full Aalto Scientific company page
